Other Events ·
Pulse Biosciences partners with Clayman Thyroid Center for commercial and clinical use of nPulse Vybrance System
PLSEPulse Biosciences, Inc.
Pulse Biosciences announced a commercial and clinical partnership with the Clayman Thyroid Center at the Hospital for Endocrine Surgery in Tampa, Florida. The agreement allows the center to treat patients using the company's proprietary nPulse Vybrance Percutaneous Electrode System for symptomatic benign thyroid nodules as part of its controlled market development strategy. Additionally, Pulse Biosciences will collaborate with the center to generate real-world outcomes data and conduct formal clinical studies evaluating nanosecond pulsed field ablation energy for this indication. This partnership expands access to the technology in a high-volume regional hub while supporting evidence generation for broader adoption. Pulse Biosciences is a bioelectric medicine company developing proprietary nanosecond pulsed field ablation technology for medical treatments.